Wed, November 16, 2022

Jonathan Wolleben Initiated (SPRB) at Buy and Held Target at $8 on, Nov 16th, 2022

Jonathan Wolleben of JMP Securities, Initiated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $8 on, Nov 16th, 2022.

Jonathan, nor any peers, have made any analyst calls on SPRB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30